TKPHF
Price
$29.31
Change
+$1.11 (+3.94%)
Updated
Sep 24 closing price
Capitalization
47.11B
VTRS
Price
$9.52
Change
+$0.03 (+0.32%)
Updated
Sep 26 closing price
Capitalization
11.1B
44 days until earnings call
Interact to see
Advertisement

TKPHF vs VTRS

Header iconTKPHF vs VTRS Comparison
Open Charts TKPHF vs VTRSBanner chart's image
Takeda Pharmaceutical
Price$29.31
Change+$1.11 (+3.94%)
Volume$66.39K
Capitalization47.11B
Viatris
Price$9.52
Change+$0.03 (+0.32%)
Volume$7.47M
Capitalization11.1B
TKPHF vs VTRS Comparison Chart in %
Loading...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TKPHF vs. VTRS commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TKPHF is a StrongBuy and VTRS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (TKPHF: $29.31 vs. VTRS: $9.52)
Brand notoriety: TKPHF and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TKPHF: 47% vs. VTRS: 75%
Market capitalization -- TKPHF: $46.76B vs. VTRS: $11.1B
TKPHF [@Pharmaceuticals: Generic] is valued at $46.76B. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $11.1B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TKPHF’s FA Score shows that 2 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • TKPHF’s FA Score: 2 green, 3 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, both TKPHF and VTRS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TKPHF’s TA Score shows that 4 TA indicator(s) are bullish while VTRS’s TA Score has 5 bullish TA indicator(s).

  • TKPHF’s TA Score: 4 bullish, 4 bearish.
  • VTRS’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, TKPHF is a better buy in the short-term than VTRS.

Price Growth

TKPHF (@Pharmaceuticals: Generic) experienced а +3.94% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was -3.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

VTRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.1B) has a higher market cap than VTRS($11.1B). VTRS has higher P/E ratio than TKPHF: VTRS (236.20) vs TKPHF (50.98). TKPHF YTD gains are higher at: 9.570 vs. VTRS (-20.571). TKPHF has higher annual earnings (EBITDA): 1.13T vs. VTRS (-493.3M). TKPHF has more cash in the bank: 419B vs. VTRS (809M). VTRS has less debt than TKPHF: VTRS (14.8B) vs TKPHF (4.51T). TKPHF has higher revenues than VTRS: TKPHF (4.48T) vs VTRS (14.1B).
TKPHFVTRSTKPHF / VTRS
Capitalization47.1B11.1B424%
EBITDA1.13T-493.3M-228,056%
Gain YTD9.570-20.571-47%
P/E Ratio50.98236.2022%
Revenue4.48T14.1B31,773%
Total Cash419B809M51,792%
Total Debt4.51T14.8B30,446%
FUNDAMENTALS RATINGS
TKPHF vs VTRS: Fundamental Ratings
TKPHF
VTRS
OUTLOOK RATING
1..100
3170
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8996
PRICE GROWTH RATING
1..100
6059
P/E GROWTH RATING
1..100
271
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (5) in the null industry is in the same range as VTRS (11). This means that TKPHF’s stock grew similarly to VTRS’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as VTRS (100). This means that TKPHF’s stock grew similarly to VTRS’s over the last 12 months.

TKPHF's SMR Rating (89) in the null industry is in the same range as VTRS (96). This means that TKPHF’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's Price Growth Rating (59) in the null industry is in the same range as TKPHF (60). This means that VTRS’s stock grew similarly to TKPHF’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as TKPHF (27). This means that VTRS’s stock grew similarly to TKPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TKPHFVTRS
RSI
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
62%
Momentum
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
62%
MACD
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
47%
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
62%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
69%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
51%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
47%
Bearish Trend 3 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QFLR32.850.19
+0.60%
Innovator Nasdaq-100 Managed Floor ETF
PQJA27.990.08
+0.30%
PGIM NASDAQ-100 BUFFER 12 ETF - JANUARY
TIPX19.26N/A
N/A
SPDR® Blmbg 1-10 Year TIPS ETF
FEUS72.11N/A
N/A
FlexShares ESG & Clmt US Lrg Cap Cr Idx
JDOC50.40N/A
N/A
JPMorgan Healthcare Leaders ETF

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TCNNF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TCNNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TCNNF - TKPHF
14%
Poorly correlated
+1.09%
VTRS - TKPHF
11%
Poorly correlated
+0.32%
SGIOY - TKPHF
9%
Poorly correlated
+1.39%
SFOSF - TKPHF
7%
Poorly correlated
N/A
RSCI - TKPHF
2%
Poorly correlated
N/A
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+0.32%
ELAN - VTRS
54%
Loosely correlated
+3.65%
ZTS - VTRS
48%
Loosely correlated
+1.68%
AMRX - VTRS
44%
Loosely correlated
+1.56%
EBS - VTRS
43%
Loosely correlated
+1.95%
COLL - VTRS
38%
Loosely correlated
-0.69%
More